ABIO Annual SG&A
$6.28 M
+$436.00 K+7.46%
31 December 2023
Summary:
As of February 5, 2025, ABIO annual selling, general & administrative expenses is $6.28 million, with the most recent change of +$436.00 thousand (+7.46%) on December 31, 2023. During the last 3 years, it has risen by +$1.51 million (+31.61%).ABIO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Quarterly SG&A
$2.99 M
+$675.00 K+29.13%
30 June 2024
Summary:
As of February 5, 2025, ABIO quarterly selling, general & administrative expenses is $2.99 million, with the most recent change of +$675.00 thousand (+29.13%) on June 30, 2024. Over the past year, it has increased by +$1.45 million (+93.91%).ABIO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO TTM SG&A
-$760.57 M
-$7.20 M-0.96%
30 June 2024
Summary:
As of February 5, 2025, ABIO TTM selling, general & administrative expenses is -$760.57 million, with the most recent change of -$7.20 million (-0.96%) on June 30, 2024. Over the past year, it has dropped by -$766.85 million (-12205.22%).ABIO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.5% | +93.9% | -10000.0% |
3 y3 years | +31.6% | +134.1% | -10000.0% |
5 y5 years | +62.0% | +134.1% | -10000.0% |
ABIO Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -79.5% | -70.7% | -2582.6% |
ARCA Biopharma Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $2.99 M(+29.1%) | $8.47 M(+17.7%) |
Mar 2024 | - | $2.32 M(+50.2%) | $7.19 M(+14.5%) |
Dec 2023 | $6.28 M(+7.5%) | $1.54 M(-4.5%) | $6.28 M(+0.9%) |
Sept 2023 | - | $1.61 M(-6.1%) | $6.23 M(+1.4%) |
June 2023 | - | $1.72 M(+22.3%) | $6.14 M(-0.2%) |
Mar 2023 | - | $1.41 M(-5.4%) | $6.16 M(+5.3%) |
Dec 2022 | $5.85 M(+6.3%) | $1.49 M(-2.7%) | $5.85 M(-4.1%) |
Sept 2022 | - | $1.53 M(-11.9%) | $6.10 M(+4.3%) |
June 2022 | - | $1.73 M(+57.9%) | $5.85 M(+8.8%) |
Mar 2022 | - | $1.10 M(-36.9%) | $5.38 M(-2.3%) |
Dec 2021 | $5.50 M(+15.3%) | $1.74 M(+36.1%) | $5.50 M(-3.2%) |
Sept 2021 | - | $1.28 M(+1.4%) | $5.69 M(+6.3%) |
June 2021 | - | $1.26 M(+2.8%) | $5.35 M(+6.4%) |
Mar 2021 | - | $1.23 M(-36.2%) | $5.03 M(+5.3%) |
Dec 2020 | $4.77 M(+19.9%) | $1.92 M(+104.7%) | $4.77 M(+27.4%) |
Sept 2020 | - | $939.00 K(+0.1%) | $3.75 M(+1.1%) |
June 2020 | - | $938.00 K(-3.8%) | $3.71 M(-3.4%) |
Mar 2020 | - | $975.00 K(+9.1%) | $3.84 M(-3.6%) |
Dec 2019 | $3.98 M(+2.6%) | $894.00 K(-0.7%) | $3.98 M(-0.2%) |
Sept 2019 | - | $900.00 K(-15.7%) | $3.99 M(-0.5%) |
June 2019 | - | $1.07 M(-4.6%) | $4.01 M(+1.7%) |
Mar 2019 | - | $1.12 M(+24.1%) | $3.94 M(+1.7%) |
Dec 2018 | $3.88 M(-16.3%) | $902.00 K(-2.2%) | $3.88 M(-12.6%) |
Sept 2018 | - | $922.00 K(-8.0%) | $4.44 M(-1.4%) |
June 2018 | - | $1.00 M(-4.8%) | $4.50 M(-1.1%) |
Mar 2018 | - | $1.05 M(-28.0%) | $4.55 M(-1.8%) |
Dec 2017 | $4.64 M(+8.7%) | $1.46 M(+48.2%) | $4.64 M(+6.7%) |
Sept 2017 | - | $987.00 K(-6.1%) | $4.34 M(-0.1%) |
June 2017 | - | $1.05 M(-7.4%) | $4.35 M(+0.5%) |
Mar 2017 | - | $1.14 M(-3.1%) | $4.33 M(+1.4%) |
Dec 2016 | $4.26 M(-2.9%) | $1.17 M(+18.0%) | $4.26 M(-2.5%) |
Sept 2016 | - | $992.00 K(-3.5%) | $4.38 M(-2.4%) |
June 2016 | - | $1.03 M(-4.3%) | $4.49 M(+1.3%) |
Mar 2016 | - | $1.07 M(-16.2%) | $4.43 M(+0.8%) |
Dec 2015 | $4.39 M(+8.0%) | $1.28 M(+16.4%) | $4.39 M(+6.1%) |
Sept 2015 | - | $1.10 M(+13.3%) | $4.14 M(+3.8%) |
June 2015 | - | $972.00 K(-6.3%) | $3.99 M(-0.8%) |
Mar 2015 | - | $1.04 M(+0.7%) | $4.02 M(-1.1%) |
Dec 2014 | $4.07 M(+1.4%) | $1.03 M(+8.4%) | $4.07 M(-3.1%) |
Sept 2014 | - | $950.00 K(-5.6%) | $4.20 M(-1.4%) |
June 2014 | - | $1.01 M(-7.0%) | $4.26 M(+1.3%) |
Mar 2014 | - | $1.08 M(-6.7%) | $4.21 M(+4.8%) |
Dec 2013 | $4.01 M(+24.3%) | $1.16 M(+14.7%) | $4.01 M(+14.6%) |
Sept 2013 | - | $1.01 M(+6.2%) | $3.50 M(+7.3%) |
June 2013 | - | $952.00 K(+7.1%) | $3.26 M(+4.1%) |
Mar 2013 | - | $889.00 K(+37.2%) | $3.13 M(-2.9%) |
Dec 2012 | $3.23 M(-36.0%) | $648.00 K(-16.1%) | $3.23 M(-10.8%) |
Sept 2012 | - | $772.00 K(-6.2%) | $3.62 M(-12.5%) |
June 2012 | - | $823.00 K(-16.4%) | $4.13 M(-8.5%) |
Mar 2012 | - | $984.00 K(-5.3%) | $4.52 M(-10.5%) |
Dec 2011 | $5.05 M(-16.9%) | $1.04 M(-19.3%) | $5.05 M(-8.2%) |
Sept 2011 | - | $1.29 M(+6.7%) | $5.50 M(-1.6%) |
June 2011 | - | $1.21 M(-20.2%) | $5.59 M(-6.1%) |
Mar 2011 | - | $1.51 M(+1.3%) | $5.95 M(-1.9%) |
Dec 2010 | $6.07 M | $1.49 M(+8.1%) | $6.07 M(-2.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2010 | - | $1.38 M(-12.0%) | $6.22 M(-9.2%) |
June 2010 | - | $1.57 M(-3.6%) | $6.85 M(-25.1%) |
Mar 2010 | - | $1.63 M(-1.2%) | $9.14 M(-28.8%) |
Dec 2009 | $12.84 M(+51.6%) | $1.65 M(-17.9%) | $12.84 M(+54.7%) |
Sept 2009 | - | $2.01 M(-48.0%) | $8.30 M(-16.9%) |
June 2009 | - | $3.86 M(-27.5%) | $9.99 M(+26.9%) |
Mar 2009 | - | $5.32 M(-284.1%) | $7.88 M(+20.0%) |
Dec 2008 | $8.47 M(-59.2%) | -$2.89 M(-178.2%) | $6.56 M(-50.9%) |
Sept 2008 | - | $3.70 M(+111.9%) | $13.37 M(-3.6%) |
June 2008 | - | $1.75 M(-56.5%) | $13.88 M(-28.5%) |
Mar 2008 | - | $4.01 M(+2.3%) | $19.41 M(-6.5%) |
Dec 2007 | $20.76 M(-32.2%) | $3.92 M(-6.8%) | $20.76 M(-11.4%) |
Sept 2007 | - | $4.20 M(-42.2%) | $23.44 M(-9.2%) |
June 2007 | - | $7.27 M(+35.5%) | $25.80 M(+0.0%) |
Mar 2007 | - | $5.37 M(-18.7%) | $25.79 M(-15.8%) |
Dec 2006 | $30.63 M(+93.8%) | $6.60 M(+0.5%) | $30.64 M(+6.7%) |
Sept 2006 | - | $6.57 M(-9.6%) | $28.70 M(+9.1%) |
June 2006 | - | $7.26 M(-28.9%) | $26.31 M(+18.5%) |
Mar 2006 | - | $10.21 M(+118.8%) | $22.20 M(+40.5%) |
Dec 2005 | $15.80 M(+78.2%) | $4.67 M(+11.8%) | $15.80 M(+14.8%) |
Sept 2005 | - | $4.17 M(+32.5%) | $13.77 M(+12.9%) |
June 2005 | - | $3.15 M(-17.4%) | $12.19 M(+10.9%) |
Mar 2005 | - | $3.81 M(+45.0%) | $10.99 M(+23.9%) |
Dec 2004 | $8.87 M(-41.1%) | $2.63 M(+1.1%) | $8.87 M(+28.1%) |
Sept 2004 | - | $2.60 M(+33.2%) | $6.93 M(-3.6%) |
June 2004 | - | $1.95 M(+15.6%) | $7.19 M(-44.3%) |
Mar 2004 | - | $1.69 M(+146.6%) | $12.91 M(-14.3%) |
Dec 2003 | $15.07 M(+0.6%) | $685.00 K(-76.1%) | $15.07 M(-25.6%) |
Sept 2003 | - | $2.86 M(-62.7%) | $20.26 M(-0.1%) |
June 2003 | - | $7.67 M(+99.5%) | $20.28 M(+28.6%) |
Mar 2003 | - | $3.85 M(-34.6%) | $15.77 M(+5.3%) |
Dec 2002 | $14.98 M(+11.4%) | $5.88 M(+104.2%) | $14.98 M(+17.5%) |
Sept 2002 | - | $2.88 M(-9.0%) | $12.75 M(-5.4%) |
June 2002 | - | $3.17 M(+3.5%) | $13.47 M(-0.3%) |
Mar 2002 | - | $3.06 M(-16.2%) | $13.51 M(+0.4%) |
Dec 2001 | $13.45 M(+44.4%) | $3.65 M(+1.2%) | $13.45 M(+13.8%) |
Sept 2001 | - | $3.60 M(+12.6%) | $11.82 M(+13.2%) |
June 2001 | - | $3.20 M(+6.6%) | $10.45 M(+7.4%) |
Mar 2001 | - | $3.00 M(+48.7%) | $9.73 M(+4.4%) |
Dec 2000 | $9.31 M(+15.0%) | $2.02 M(-9.3%) | $9.31 M(-3.9%) |
Sept 2000 | - | $2.23 M(-10.3%) | $9.70 M(+4.6%) |
June 2000 | - | $2.48 M(-4.2%) | $9.27 M(+7.9%) |
Mar 2000 | - | $2.59 M(+7.9%) | $8.59 M(+4.8%) |
Dec 1999 | $8.10 M(-14.7%) | $2.40 M(+33.3%) | $8.20 M(0.0%) |
Sept 1999 | - | $1.80 M(0.0%) | $8.20 M(-8.9%) |
June 1999 | - | $1.80 M(-18.2%) | $9.00 M(-6.3%) |
Mar 1999 | - | $2.20 M(-8.3%) | $9.60 M(+1.1%) |
Dec 1998 | $9.50 M(+93.9%) | $2.40 M(-7.7%) | $9.50 M(+5.6%) |
Sept 1998 | - | $2.60 M(+8.3%) | $9.00 M(+18.4%) |
June 1998 | - | $2.40 M(+14.3%) | $7.60 M(+26.7%) |
Mar 1998 | - | $2.10 M(+10.5%) | $6.00 M(+25.0%) |
Dec 1997 | $4.90 M(+188.2%) | $1.90 M(+58.3%) | $4.80 M(+65.5%) |
Sept 1997 | - | $1.20 M(+50.0%) | $2.90 M(+70.6%) |
June 1997 | - | $800.00 K(-11.1%) | $1.70 M(+88.9%) |
Mar 1997 | - | $900.00 K | $900.00 K |
Dec 1996 | $1.70 M | - | - |
FAQ
- What is ARCA biopharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for ARCA biopharma?
- What is ARCA biopharma annual SG&A year-on-year change?
- What is ARCA biopharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for ARCA biopharma?
- What is ARCA biopharma quarterly SG&A year-on-year change?
- What is ARCA biopharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for ARCA biopharma?
- What is ARCA biopharma TTM SG&A year-on-year change?
What is ARCA biopharma annual selling, general & administrative expenses?
The current annual SG&A of ABIO is $6.28 M
What is the all time high annual SG&A for ARCA biopharma?
ARCA biopharma all-time high annual selling, general & administrative expenses is $30.63 M
What is ARCA biopharma annual SG&A year-on-year change?
Over the past year, ABIO annual selling, general & administrative expenses has changed by +$436.00 K (+7.46%)
What is ARCA biopharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of ABIO is $2.99 M
What is the all time high quarterly SG&A for ARCA biopharma?
ARCA biopharma all-time high quarterly selling, general & administrative expenses is $10.21 M
What is ARCA biopharma quarterly SG&A year-on-year change?
Over the past year, ABIO quarterly selling, general & administrative expenses has changed by +$1.45 M (+93.91%)
What is ARCA biopharma TTM selling, general & administrative expenses?
The current TTM SG&A of ABIO is -$760.57 M
What is the all time high TTM SG&A for ARCA biopharma?
ARCA biopharma all-time high TTM selling, general & administrative expenses is $30.64 M
What is ARCA biopharma TTM SG&A year-on-year change?
Over the past year, ABIO TTM selling, general & administrative expenses has changed by -$766.85 M (-12205.22%)